M&T Bank
ONCE

M&T Bank’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

M&T Bank’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,850
Closed -$286K – 1871
2015
Q3 		$286K Buy
+6,850
New +$357K ﹤0.01% 1336

Other funds holding ONCE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

M&T Bank's ONCE Position: Q4 2015 in Review

M&T Bank sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2015, closing a stake of 6,850 shares — an estimated $286K sold.

M&T Bank first reported a position in ONCE in Q3 2015 and held it in 1 quarter. The position peaked at $286K in Q3 2015. 102 funds tracked by Wall St. Rank hold ONCE as of Q4 2015.

  • M&T Bank reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • M&T Bank sold 6,850 Spark Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $286K.
  • M&T Bank first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • M&T Bank's Spark Therapeutics, Inc. Common Stock position peaked at $286K in Q3 2015.
  • 102 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2015.

Based on M&T Bank's 13F filing for Q4 2015, filed 12 Feb 2016.